Editas Medicine (EDIT) Price to FCF (2016 - 2025)
Powered by 
Analysis
Editas Medicine (EDIT) Price to FCF (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.26 Bn | 130.41 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.12 Bn | 77.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.22 Bn | 58.04 Bn | 1.37 Bn |
| 4 | Moderna | 58.13 Bn | 52.99 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.09 Bn | 44.09 Bn | - |
| 6 | BeOne Medicines | 40.00 Bn | 34.91 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.36 Bn | 27.52 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Editas Medicine | 284.24 Mn | 137.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10.49 |
| Jun 30, 2025 | -3.83 |
| Mar 31, 2025 | -2.08 |
| Dec 31, 2024 | -2.05 |
| Sep 30, 2024 | -5.07 |
| Jun 30, 2024 | -6.36 |
| Mar 31, 2024 | -11.79 |
| Dec 31, 2023 | -35.18 |
| Sep 30, 2023 | -17.84 |
| Jun 30, 2023 | -16.77 |
| Mar 31, 2023 | -13.30 |
| Dec 31, 2022 | -14.24 |
| Sep 30, 2022 | -17.31 |
| Jun 30, 2022 | -21.13 |
| Mar 31, 2022 | -25.35 |
| Dec 31, 2021 | -48.55 |
| Sep 30, 2021 | -65.07 |
| Jun 30, 2021 | -97.10 |
| Mar 31, 2021 | -55.06 |
| Dec 31, 2020 | -105.76 |